Formulation and Packaging Sample Clauses

Formulation and Packaging. In all events, NOVARTIS will be responsible for formulation and packaging of Drug Products.
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
Formulation and Packaging. QLT shall be responsible for formulation and packaging of Collaboration Products, including the costs thereof. [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Sample 1
Formulation and Packaging. Chelsea shall at its sole cost, expense, risk and responsibility carry out the formulation and packaging of the Finished Product. The formulation and packaging shall be carried out in compliance with any and all applicable laws and regulations of the Territory. Chelsea shall not sell, by itself through its Affiliates and Sublicensees, the Finished Product which does not meet the then-prevailing quality, specifications and test methods, formula and manufacturing process. Chelsea shall at DSP’s request and Chelsea’s expense, provide DSP with an appropriate unit of samples of the Finished Product, together with manufacturing report including certificate of analysis.
Sample 1
Formulation and Packaging. ‌ Sufficient quantities of VI-0521, phentermine and topiramate capsules will be supplied by the sponsor in blister cards and bottles and shipped to a designee at the study site. All clinical supplies will be labeled with information required by national and/or international regulations. Study drug will be packaged into 2 types of kits; titration kits (blister cards) for use during the first 4 weeks of study treatment and the titration period during study Weeks 13-16, and treatment kits (bottles), for use once subjects have been titrated to their assigned dose. Each titration kit contains 1 blister card for use during Weeks 1 through 4 of titration, with each card containing 4 columns of 8 capsules each. Each column on the blister card will be labeled with the week number (1 through 4) and will contain capsules with the dose specified for that week of treatment, as outlined in Table 1. Titration kits will consist of blister cards labeled with the study number, a unique kit number, storage instructions, and spaces for the subject number and initials. Treatment kits will consist of bottles, each containing 35 capsules of study medication at the treatment dosages shown in Table 1. Each kit will contain a single bottle labeled with the study number, a unique kit number, storage instruction, and spaces for the subject number and initials. Table 1: VI-0521 Dosage Strengths by Titration Week for Each Treatment Group‌ Group Treatment Dosage for Phentermine/Topiramate (mg) Titration Dose for Phentermine/Topiramate (mg) Weeks 1-2 Weeks 3-4 Weeks 13-14 Weeks 15-16 Placebo 0/0 0/0 0/0 0/0 0/0 VI-0521 Mid 7.5/46 3.75/23 7.5/46 7.5/46 7.5/46 VI-0521 Top 15/92 3.75/23 7.5/46 11.25/69 15/92
Sample 1

Related to Formulation and Packaging

  • Packaging Tangible product shall be securely and properly packed for shipment, storage, and stocking in appropriate, clearly labeled, shipping containers and according to accepted commercial practice, without extra charge for packing materials, cases, or other types of containers. All containers and packaging shall become and remain Customer’s property.

  • Manufacturing (a) The Supplier shall without limitation be responsible, at no additional cost to the Purchaser, for: sourcing and procuring all raw materials for the Products; obtaining all necessary approvals, permits and licenses for the manufacturing of the Products; providing sufficient qualified staff and workers to perform the obligations under this Purchase Agreement; implementing and maintaining effective inventory and production control procedures with respect to the Products; and handling other matters as reasonably requested by the Purchaser from time to time.

  • Packaging and Labeling Seller shall properly xxxx, xxxx, and ship Goods and provide Buyer with shipment documentation showing the Order number, Seller’s identification number for the subject Goods, the quantity of goods in shipment and the number of cartons or containers in the shipment.

  • Labelling The distributor, on behalf of the selected vendor agrees that all supplies of articles should invariably contain the following information on its label and the carton. One information should not be overlapped by any other information needed to be furnished. The label should contain :

  • API If the Software offers integration capabilities via an API, your use of the API may be subject to additional costs or Sage specific policies and terms and conditions (which shall prevail in relation to your use of the API). You may not access or use the API in any way that could cause damage to us or the Software, or in contravention of any applicable laws. We reserve the right in our sole discretion, to: (i) update any API from time to time; (ii) place limitations around your use of any API; and (iii) deny you access to any API in the event of misuse by you or to otherwise protect our legitimate interests.

  • Labeling Upon request, Lessee will xxxx the Equipment indicating Lessor's interest with labels provided by Lessor. Lessee will keep all Equipment free from any other marking or labeling which might be interpreted as a claim of ownership.

  • SPECIAL PACKAGING Items shall be packaged and cartoned so as to protect the contents from damage during shipment, handling and storage. Shipping container shall have a label with the following information: Name of Receiving Agency Agency Purchase Order Number Name of Supplier Item Description of Contents Manufacturer Name Model Name and Number

  • Marketing Materials (a) During the term of this Agreement, the Sub-Adviser agrees to furnish the Manager at its principal office for prior review and approval by the Manager all written and/or printed materials, including but not limited to, PowerPointÒ or slide presentations, news releases, advertisements, brochures, fact sheets and other promotional, informational or marketing materials (the “Marketing Materials”) for internal use or public dissemination, that are produced or are for use or reference by the Sub-Adviser, its affiliates or other designees, broker-dealers or the public in connection with the Series, and Sub-Adviser shall not use any such materials if the Manager reasonably objects in writing within five business days (or such other period as may be mutually agreed) after receipt thereof. Marketing Materials may be furnished to the Manager by first class or overnight mail, facsimile transmission equipment, electronic delivery or hand delivery.

  • Vaccination and Inoculation (a) The Employer agrees to take all reasonable precautions, including in-service seminars, to limit the spread of infectious diseases among employees.

  • Packaging Materials and Containers for Retail Sale Packaging materials and containers in which a good is packaged for retail sale shall, if classified with the good, be disregarded in determining whether all the non-originating materials used in the production of the good undergo the applicable change in tariff classification set out in Annex 4, and, if the good is subject to a regional value-content requirement, the value of such packaging materials and containers shall be taken into account as originating or non-originating materials, as the case may be, in calculating the regional value content of the good.

Time is Money Join Law Insider Premium to draft better contracts faster.